Helix BioPharma

Helix BioPharma Corp. Announces Selection of CEO; Plans to Voluntarily Delist From NYSE MKT
Mon, 06/25/12 - 11:24 pm
Helix BioPharma
CEO
Helix BioPharma receives approval to conduct Phase III clinical trial
Fri, 05/18/12 - 06:51 pm
Helix BioPharma
clinical trials
regulatory
Helix BioPharma Corp. Reconstituted Board of Directors Provides Update to Shareholders
Thu, 04/5/12 - 06:51 pm
Helix BioPharma
Management
Helix BioPharma Corp. Announces Agreed Changes to the Board of Directors and Settlement With Concerned Shareholders
Wed, 03/14/12 - 10:06 pm
Helix BioPharma
Management
legal
Helix BioPharma Corp. Announces That Institutional Shareholder Services Recommends Shareholders Vote for Management's Director Nominees
Mon, 01/23/12 - 08:24 pm
Helix BioPharma
stock
Helix BioPharma Corp. Files Clinical Trial Applications for Its Planned European Phase III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions
Fri, 12/23/11 - 05:31 pm
Helix BioPharma
clinical trials
Europe
Helix BioPharma Corp. Announces Appointment of Special Committee
Wed, 11/16/11 - 10:38 pm
Helix BioPharma
Management
Clinical Hold Removed for Helix BioPharma Corp.'s Topical Interferon Alpha-2b Phase II/III Efficacy Trial IND Application
Fri, 11/11/11 - 05:14 pm
clinical trials
Helix BioPharma
Helix BioPharma Corp. Announces Fiscal 2011 Results
Mon, 10/31/11 - 10:16 pm
Helix BioPharma
earnings
Helix BioPharma Corp. Terminates Agreement With ACM Alpha Consulting Management Est.
Thu, 10/20/11 - 10:55 pm
Helix BioPharma
ACM Alpha Consulting
Helix BioPharma Corp. Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial
Wed, 10/12/11 - 08:42 pm
Helix BioPharma
FDA
clinical trial
Helix BioPharma Announces Private Placement for Net Proceeds of $2.0 Million
Thu, 03/31/11 - 12:57 pm
Helix BioPharma
cancer therapy
shareholders
investors
Helix BioPharma Corp. Announces Fiscal Q1 2011 Results
Fri, 12/10/10 - 07:43 pm
Helix BioPharma
investors
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Sat, 11/20/10 - 12:46 pm
Helix BioPharma
topical interferon Alpha-2b
cervical lesions
cervical cancer